Engineered Exosome-Mediated FIH-1 Delivery for Targeted Therapy of Hyperuricemic Nephropathy by Inhibiting NF-κB/NLRP3 Inflammasome Signaling and Restoring Autophagic Homeostasis.
- DOI
- 10.1002/adhm.71602
- Published
- 2026 Sep
- Container
- Advanced healthcare materials
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/adhm.71602,
title = {Engineered Exosome-Mediated FIH-1 Delivery for Targeted Therapy of Hyperuricemic Nephropathy by Inhibiting NF-κB/NLRP3 Inflammasome Signaling and Restoring Autophagic Homeostasis.},
author = {Xiao T and Liu Y and He Z and Yang A and Li J and Zhou L and Yang Q and Xu D and Yuan L and Chen M and Yang S},
year = {2026},
journal = {Advanced healthcare materials},
doi = {10.1002/adhm.71602},
url = {https://doi.org/10.1002/adhm.71602}
}RIS
TY - JOUR TI - Engineered Exosome-Mediated FIH-1 Delivery for Targeted Therapy of Hyperuricemic Nephropathy by Inhibiting NF-κB/NLRP3 Inflammasome Signaling and Restoring Autophagic Homeostasis. AU - Xiao T AU - Liu Y AU - He Z AU - Yang A AU - Li J AU - Zhou L AU - Yang Q AU - Xu D AU - Yuan L AU - Chen M AU - Yang S PY - 2026 JO - Advanced healthcare materials DO - 10.1002/adhm.71602 UR - https://doi.org/10.1002/adhm.71602 ER -
APA
T, X., Y, L., Z, H., A, Y., J, L., L, Z., Q, Y., D, X., L, Y., M, C., & S, Y. (2026). Engineered Exosome-Mediated FIH-1 Delivery for Targeted Therapy of Hyperuricemic Nephropathy by Inhibiting NF-κB/NLRP3 Inflammasome Signaling and Restoring Autophagic Homeostasis.. Advanced healthcare materials. https://doi.org/10.1002/adhm.71602
Source records
- pubmed · retrieved 2026-09-26T09:32:47.317Z